(Q38306886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

review article

1 reference

title

Gene delivery in tissue engineering and regenerative medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

regenerative medicine

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Y L Fang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Godbey W T

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

30 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biomedical Materials Research Part B

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

1679-1699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

History of regenerative medicine: looking backwards to move forwards

26 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Regenerative medicine and organ transplantation: past, present, and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Polymers for gene delivery across length scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Nonviral gene delivery: what we know and what is next

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Adeno-associated virus type 2 preferentially integrates single genome copies with defined breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Frequency and spectrum of genomic integration of recombinant adeno-associated virus serotype 8 vector in neonatal mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Immune responses to AAV vectors: overcoming barriers to successful gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Use of nonintegrating lentiviral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Stable gene transfer to muscle using non-integrating lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Integrase-defective lentiviral vectors: progress and applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Transient gene expression mediated by integrase-defective retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Viral vectors for gene delivery in tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Local and retrograde gene transfer into primate neuronal pathways via adeno-associated virus serotype 8 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Efficient gene transfer into neurons in monkey brain by adeno-associated virus 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Self-complementary AAV vectors; advances and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Effect of ultrasound on herpes simplex virus infection in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Ultrasound microbubbles enhance recombinant adeno-associated virus vector delivery to retinal ganglion cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Angelica sinensis polysaccharide nanoparticles as novel non-viral carriers for gene delivery to mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Enhanced bioactivity of internally functionalized cationic dendrimers with PEG cores

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Integration of adeno-associated virus-derived peptides into nonviral vectors to synergistically enhance cellular transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

TAT conjugated cationic noble metal nanoparticles for gene delivery to epidermal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Direct head-to-head comparison of cationic liposome-mediated gene delivery to mesenchymal stem/stromal cells of different human sources: a comprehensive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Efficient generation of virus-free iPS cells using liposomal magnetofection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Polyethyleneimine-mediated gene delivery into human adipose derived stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Comparison of gene-transfer efficiency in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

High-intensity focused ultrasound: current potential and oncologic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Synergistic ablation of liver tissue and liver cancer cells with high-intensity focused ultrasound and ethanol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Effect of ethanol injection on cavitation and heating of tissues exposed to high-intensity focused ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-beta1 for chondrocytes proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Novel gene-activated matrix with embedded chitosan/plasmid DNA nanoparticles encoding PDGF for periodontal tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Matrix-mediated gene transfer to brain cortex and dorsal root ganglion neurones by retrograde axonal transport after dorsal column lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Mechanisms governing lentivirus integration site selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Emerging use of stem cells in regenerative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Stem cells. Setting standards for human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Introduction to stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Establishment in culture of pluripotential cells from mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Characterization of human embryonic stem cell lines by the International Stem Cell Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: distinct requirements for TGF-beta and IGF-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Automated, scalable culture of human embryonic stem cells in feeder-free conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Human embryonic stem cells derived without feeder cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Human embryonic stem cells and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Induced pluripotent stem cells generated without viral integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Human induced pluripotent stem cells free of vector and transgene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

A nonviral minicircle vector for deriving human iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

The generation of iPS cells using non-viral magnetic nanoparticle based transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Induced pluripotent stem cells: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Transcriptional signature and memory retention of human-induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Pluripotency: toward a gold standard for human ES and iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Mesenchymal stem cell homing: the devil is in the details

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Stem cells derived from amniotic fluid: new potentials in regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Isolation of amniotic stem cell lines with potential for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Pluripotency factors regulate definitive endoderm specification through eomesodermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Vertebrate endoderm development and organ formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Advances in signaling in vertebrate regeneration as a prelude to regenerative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Genes inducing iPS phenotype play a role in hepatocyte survival and proliferation in vitro and liver regeneration in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Generation and regeneration of cells of the liver and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Isolation and transcriptional profiling of purified hepatic cells derived from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

In vitro hepatic differentiation of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Adipose tissue-derived mesenchymal stem cell-based liver gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Transplantation of bone marrow-derived hepatocyte stem cells transduced with adenovirus-mediated IL-10 gene reverses liver fibrosis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Oval cell-mediated liver regeneration: Role of cytokines and growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Induced pluripotent stem cells: a new era for hepatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Non-viral FoxM1 gene delivery to hepatocytes enhances liver repopulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

A dual-functionally modified chitosan derivative for efficient liver-targeted gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Ultrasound-targeted microbubble destruction-mediated gene delivery into canine livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Hepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

The treatment of liver fibrosis induced by hepatocyte growth factor-directed, ultrasound-targeted microbubble destruction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Increased expression of hepatocyte nuclear factor 6 stimulates hepatocyte proliferation during mouse liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Combinatorial gene therapy induces regression of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Induction of pancreatic stem/progenitor cells into insulin-producing cells by adenoviral-mediated gene transfer technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Intra-arterial targeted islet-specific expression of Sirt1 protects β cells from streptozotocin-induced apoptosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Adenoviral vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

In vivo gene transfer to pancreatic beta cells by systemic delivery of adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

In vivo gene transfer to healthy and diabetic canine pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

In vivo reprogramming of adult pancreatic exocrine cells to beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Efficient and persistent transduction of exocrine and endocrine pancreas by adeno-associated virus type 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Vascularization is the key challenge in tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Endothelial cell-matrix interactions in neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Angiogenesis in life, disease and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Endothelial progenitor cell-based neovascularization: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

VEGF is important for early liver regeneration after partial hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Bone marrow stromal cells with a combined expression of BMP-2 and VEGF-165 enhanced bone regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Enhancement of sciatic nerve regeneration after vascular endothelial growth factor (VEGF) gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Gene therapy for bone regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Bone morphogenetic proteins in clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Comparison of osteogenic potentials of BMP4 transduced stem cells from autologous bone marrow and fat tissue in a rabbit model of calvarial defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

NELL1 promotes high-quality bone regeneration in rat femoral distraction osteogenesis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Gene therapy for the regeneration of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Improved cartilage regeneration utilizing mesenchymal stem cells in TGF-beta1 gene-activated scaffolds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

A strategy to establish a gene-activated matrix on titanium using gene vectors protected in a polylactide coating.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Enhanced bone regeneration with sequential delivery of basic fibroblast growth factor and sonic hedgehog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Localized viral vector delivery to enhance in situ regenerative gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Bone regeneration by regulated in vivo gene transfer using biocompatible polyplex nanomicelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

PDGF-B gene therapy accelerates bone engineering and oral implant osseointegration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Skeletal muscle: increasing the size of the locomotor cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Expression of dog microdystrophin in mouse and dog muscles by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Beta-catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Gene therapy and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Gene therapy in wound healing: present status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

A new technique of ex vivo gene delivery of VEGF to wounds using genetically modified skin particles promotes wound angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Assessment of optimal virus-mediated growth factor gene delivery for human cutaneous wound healing enhancement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Efficient in vivo targeting of epidermal stem cells by early gestational intraamniotic injection of lentiviral vector driven by the keratin 5 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Bioactivation of dermal scaffolds with a non-viral copolymer-protected gene vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Delivery of plasmid DNA expression vector for keratinocyte growth factor-1 using electroporation to improve cutaneous wound healing in a septic rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Enhancement of regeneration with glia cell line-derived neurotrophic factor-transduced human amniotic fluid mesenchymal stem cells after sciatic nerve crush injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Optimizing neurotrophic factor combinations for neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Schwann cell transplantation for CNS repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Chitosan/siRNA nanoparticles biofunctionalize nerve implants and enable neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

The deployment of adenovirus-containing gene activated matrices onto severed axons after central nervous system injury leads to transgene expression in target neuronal cell bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Gene transfer to dorsal root ganglia by intrathecal injection: effects on regeneration of peripheral nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Spinal gene transfer using ultrasound and microbubbles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

GDNF-transduced Schwann cell grafts enhance regeneration of erectile nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Adenoviral gene transfer of bone morphogenetic protein-7 enhances functional recovery after sciatic nerve injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Saposin C: neuronal effect and CNS delivery by liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Progress in understanding reprogramming to the induced pluripotent state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Stepwise differentiation of human adipose-derived mesenchymal stem cells toward definitive endoderm and pancreatic progenitor cells by mimicking pancreatic development in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Assessing the potential for AAV vector genotoxicity in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.33354

21 January 2018

Identifiers

DOI

10.1002/JBM.B.33354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25557560%20AND%20SRC:MED&resulttype=core&format=json